Aramis Biosciences Launches to Address Unmet Needs in

Founded by Renowned Experts in Ophthalmology and Immunology Launches with $10.5 million Series A Financing Led by Safar Partners to Advance...

Related Keywords

Italy ,Boston ,Massachusetts ,United States ,Milan ,Lombardia ,Ireland ,Massachusetts Institute Of Technology ,Sunil Chauhan ,Aramis Bio ,Aramis Biosciences ,Reza Dana ,Guido Romeo ,Marcello Allegretti ,Aramis Bioscience ,Davids Tierney ,Claes Dohlman ,Icon Bioscience Inc ,Head Corporate Communications ,Ophthalmology At Harvard Medical School ,Scientific Co ,Nasdaq ,Biopharmx Corporation ,Laboratory Of Corneal Immunology ,Valera Pharmaceuticals ,Schepens Eye Research Institute Of Mass ,University Of Rochester ,Bausch Health ,Cornea Service At Mass Eye ,Professor Of Ophthalmology At Harvard Medical School ,Department Of Ophthalmology At Harvard Medical School ,Endo Pharmaceuticals ,Harvard Medical School Committee On Immunology ,Shire Pharmaceuticals ,Salix Pharmaceuticals ,Oceana Therapeutics Inc ,Aramis Biosciences Inc ,Royal College Of Surgeons ,Elan Corporation ,Eyepoint Pharmaceuticals Inc ,Renowned Experts ,Financing Led ,Safar Partners ,Advance Disease Modifying Therapy ,Ocular Surface Disease ,Schepens Eye Research Institute ,Mass Eye ,Harvard Medical School ,Scientific Co Founder ,Corneal Disorders ,Ocular Inflammation ,Claes Dohlman Chair ,Harvard Medical ,Cornea Service ,Senior Scientist ,Corneal Immunology ,Harvard Medical School Committee ,Associate Professor ,Associate Scientist ,Chief Scientific Officer ,Icon Bioscience ,Eyepoint Pharmaceuticals ,New Drug Application ,Oceana Therapeutics ,Roberts Pharmaceutical ,Royal College ,Aramis Bioscience President ,Massachusetts Institute ,Nerve Growth ,San Francisco Bay Area ,